Morgan Stanley downgraded Melexis (MLXSF) to Equal Weight from Overweight with a price target of EUR 55, down from EUR 80. The company’s fiscal 2026 outlook breaks the narrative of a growth and margin recovery, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLXSF: